TITLE

Treatment of Helicobacter pylori in functional dyspepsia resistant to conventional management: a double blind randomised trial with a six month follow up

AUTHOR(S)
Koelz, H.R.; Arnold, R.; Stolte, M.; Fischer, M.; Blum, A.L.
PUB. DATE
January 2003
SOURCE
Gut;Jan2003, Vol. 52 Issue 1, p40
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Previous studies on the treatment of Helicobacter pylori infection in functional dyspepsia have shown little, if any, effect on dyspeptic symptoms. However, whether such treatment might be of benefit in patients resistant to acid inhibitors has not been formally tested. Aim: The present study investigated the effect of H pylori treatment in patients with functional dyspepsia resistant to conventional treatment. Patients: A total of 181 H pylori positive patients with chronic functional dyspepsia who had not responded to a one week antacid run-in and two week double blind antisecretory or placebo treatment were included. Methods: Patients were randomised to two weeks of treatment with omeprazole 40 mg twice daily combined with amoxicillin 1 g twice daily or omeprazole 20 mg once daily alone. The primary outcome variable ("response") was defined as no need for further therapy or investigations for dyspeptic symptoms 4-6 months after treatment. Results: H pylori infection was healed in 10% of patients after omeprazole and in 52% after omeprazole plus amoxicillin. The respective "response" rates were 66% and 62% (NS). H pylori treatment and cure of H pylori infection had no effect on complete resolution of all dyspeptic symptoms, individual symptoms, or various aspects of quality of life. Conclusion: In functional dyspepsia, H pylori treatment and cure of H pylori are no more effective for symptoms over six months than short term acid inhibition. These results do not support treatment of H pylori in functional dyspepsia.
ACCESSION #
9758402

 

Related Articles

  • Low-dose of quadruple therapy for H. pylori infected patients treated multiple times. Dore, M.P.; Graham, D.Y.; Maragkoudakis, E.; Marras, L.; Perlepes, C.; Nieddu, S.; Manca, A.; Realdi, G. // Gut;Sep2002 Supplement 2, Vol. 51, pA94 

    Background: Although highly effective therapies are now available for curing H. pylori infection, the problem persists about what to do for patients who do not respond to two or more treatment courses despite compliance. Aim: To test a twice a day low dose quadruple therapy as salvage therapy....

  • Dyspeptic symptoms associated with Helicobacter pylori infection: Influence of strain and host specific factors. Treiber, G.G.; Schwabe, M.; Ammon, S.; Walker, S.; Klotz, U.; Malfertheiner, P. // Gut;Sep2002 Supplement 2, Vol. 51, pA96 

    Background: Dyspeptic symptoms may be associated with H. pylori infection in a subset of patients. Methods: Prospective cohort study (n = 219) with assessment of dyspeptic features at baseline and during follow-up after sucessful eradication therapy to determine whether clinical factors or...

  • Delay of diagnosis, stage of gastric cancer (GC) and survival in young gastric cancer patients without alarm symptoms (AS). Maconi, G.; Kurihana, H.; Panizzo, V.; Cristaldi, M.; Marrelli, D.; Roviello, F.; De Manzoni, G.; Di Leo, A.; Morgagni, P.; Bechi, P.; Porro, G. Bianchi; Taschieri, A.M. // Gut;Sep2002 Supplement 2, Vol. 51, pA97 

    Objective: Test and treat strategy for H. pylori infection has been recommended as cost-effective management of dyspeptic patients but has raised concern because young GC patients may have no AS. We determined the frequency of AS in a series of young GC patients and assessed the impact of...

  • Randomized study of three 'rescue' therapies for Helicobacter pylori-infected patients after failure of standard triple therapies. Pilotto, A.; Franceschi, M.; Rassu, M.; Bozzola, L.; Valerio, G.; Di Mario, F.; Leandro, G. // Gut;Sep2002 Supplement 2, Vol. 51, pA100 

    With the aim to evaluate the efficacy of three second-line regimens for the cure of H. pylori infection in patients who failed the first-line PPI-based triple-therapy we studied 45 H. pylori-positive patients (M = 18, F = 27, mean age = 68.5±14.8 years, range = 31-89 years, peptic ulcer n°...

  • Utility of treatment of H. pylori in nonulcer dyspepsia. Dale, David C.; Federman, Daniel D. // Cortlandt Forum;07/25/97, Vol. 10 Issue 7, p19 

    Describes the treatment of Helicobacter pylori in patients with nonulcer or functional dyspepsia. Test to detect the organism; Doubt about the utility of treatment.

  • Helicobacter pylori Eradication Treatment Does Not Benefit Patients With Nonulcer Dyspepsia. Froehlich, F.; Gonvers, J. J.; Wietlishach, V.; Burnand, B.; Hildebrand, P.; Schneider, C.; Saraga, E.; Beglinger, C.; Vader, J. P. // American Journal of Gastroenterology;Aug2001, Vol. 96 Issue 8, p2329 

    OBJECTIVES: The aim of this study was to assess the still controversial role of treatment of Helicobacter pylori (H. pylori) infection in patients with nonulcer dyspepsia. METHODS: We conducted a double-blind. randomized placebo- controlled. multicenter trial comparing the efficacy of 7...

  • Treating non-ulcer dyspepsia and H pylori. Veldhuyzen van Zanten, Sander J O // BMJ: British Medical Journal (International Edition);09/16/2000, Vol. 321 Issue 7262, p648 

    Editorial. Questions whether treatment of Helicobacter pylori infection leads to sustained improvement in symptoms in patients with non-ulcer dyspepsia. Symptoms and diagnosis of dyspepsia; Prevalence of H pylori in patients with dyspepsia; Diversity of outcomes used to measure improvement in...

  • Gastric mucosal biopsies in non ulcer dyspepsia: A histopathologic study. Singh, Priya; Goswami, K. C.; Gupta, Bharat Bhushan // Asian Journal of Medical Sciences;Mar/Apr2016, Vol. 7 Issue 2, p80 

    Background: Non-ulcer dyspepsia (NUD) is a major health problem and one of the most common causes of morbidity and economic loss. The aim of the study was to determine the pattern of gastric mucosal histopathologic alterations and frequency of Helicobacter pylori in patients with NUD. Materials...

  • NICE dyspepsia advice to E fuel microbial resistance. Pedder, Cato // Pulse;5/21/2005, Vol. 65 Issue 20, p8 

    Reports that a NICE guidance on treating Helicobacter pylori infection in patients with dyspepsia could lead to a surge in antibiotic resistance, according to senior government advisers in Great Britain. Discovery by a study that 59 percent of isolates were resistant to metronidazole; Advice...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics